期刊文献+

慢性阻塞性肺疾病住院患者死因及合并症分析 被引量:10

Analysis of causes of mortality and comorbidity in hospitalized chronic obstructive pulmonary patients
下载PDF
导出
摘要 目的了解慢性阻塞性肺疾病(COPD)住院患者的主要死因及合并症情况。方法回顾性分析2007年9月至2011年8月收治的1986例住院COPD患者的临床资料,其中死亡209例,分析COPD患者的主要死因及合并症情况。结果 COPD的主要死亡原因和COPD临床严重程度分级相关(P<0.01)。轻中度COPD患者70例,最常见的死亡原因是心血管系统疾病(34.3%)、肺癌(28.6%),其次是非恶性呼吸系统疾病(21.4%)。重度COPD患者50例,最常见的死亡原因是非恶性呼吸系统疾病(58.0%),其次是心血管系统疾病(24.0%)、肺癌(10.0%)。在89例极重度COPD患者中,最常见死亡原因是呼吸衰竭(43.8%)。死于肺癌的COPD患者组[(77±11)岁]较其他死亡原因组死亡年龄较轻(P<0.01)。死亡的COPD患者合并冠心病、呼吸衰竭、肺炎、心律失常、心力衰竭、消化性溃疡、肾功能不全、肿瘤、贫血、肺栓塞的比例分别为62.2%(130例)、58.9%(123例)、53.6%(112例)、36.8%(77例)、34.4%(72例)、32.1%(67例)、26.8%(56例)、26.3%(55例)、12.0%(25例)、3.3%(7例),均较存活患者发生率高(P<0.05),而高血压、糖尿病、肺结核、脑血管病等合并症两组比较差异无统计学意义(P>0.05)。结论住院COPD患者的主要死亡原因与COPD的严重程度相关。冠心病、呼吸衰竭、肺炎、心律失常、心力衰竭、消化性溃疡、肾功能不全、肿瘤、贫血等增加死亡风险。 Objective To investigate the main causes of death and comorhidities in hospitalized COPD patients. Methods The patients (n=1 986) with COPD who died (n=209) during hospitalization in our hospital from Septem- ber 2007 to August 2011 were retrospectively reviewed. The main causes of death in each stage of COPD and the rate of comorbidities were collected and analyzed. Results The predominant causes of death were related to the stage of COPD (P 〈 0.01). In patients with mild and moderate COPD (n=70), cardiovascular system disease (24, 34.3%), lung cancer (20, 28.6%) were the most common causes of death, followed by non-malignant respiratory diseases (15, 22.4%). In pa- tients with severe COPD (n=50), the predominant cause of death was non-malignant respiratory diseases (29, 58.0%), tol- lowed by cardiovascular system disease (12, 24.0%) and lung cancer (5, 10.0%). In patients with very severe COPD (n=89), the most common cause of death was respiratory failure (39, 43.8%). The lung cancer was the frequent cause of death in young patients(P 〈 0.01 ). The comorbidities including coronary heart disease(62.2%), respiratory failure(58.9%), pneumo- nia(53.6%), arrhythmia(36.8%), heart failure(34.4%), peptic ulcer(32.1%), renal insufficiency(26.8%), tumor(26.3%), ane- mia(12.0%), pulmonary embolism(3.3%) were more common in deceased patients than in survivals(P 〈 0.05). There was no statistical significance in hypertension, diabetes, pulmonary tuberculosis, cerebro-vascular disease between the deceased patients and survivals (P 〉 0.05). Conclusion The main cause of death in inpatients with COPD is related to stage COPD. The comorbidities including coronary heart disease, respiratory failure, pneumonia, arrhythmia, heart failure, peptic ulcer, renal insufficiency, tumor and anemia may increase the risk of death in COPD patients.
出处 《北京医学》 CAS 2012年第11期962-964,共3页 Beijing Medical Journal
关键词 慢性阻塞性肺疾病 死因 合并症 Chronic obstructive pulmonary disease Cause of death Comorbidity
  • 相关文献

参考文献12

  • 1Buist AS, McBumie MA, Vollmer WM, et al. International varia-tion in the prevalence of COPD (the BOLD Study): a popula-tion-based prevalence study. Lancet,2007,370:741-750.
  • 2National Institutes of Health. National Heart, Lung, and Blood In-stitute (NHLBI). Morbidity and mortality: 2009 chartbook on car-diovascular, lung, and blood diseases. 2009.
  • 3Soriano JB, Lamprecht B. Chronic obstructive pulmonary disease:a worldwide problem. Med Clin North Am,2012,96:671 -680.
  • 4慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8230
  • 5白澎,孙永昌,白澎,孙永昌.慢性阻塞性肺疾病合并症研究进展[J].国际呼吸杂志,2011,31(9):700-703. 被引量:21
  • 6Anthonisen NR, Skeans MA, Wise RA, et al. The effects of asmoking cessation intervention on 14.5-year mortality: a random-ized clinical trial. Ann Intern Med,2005,142:233-239.
  • 7Burge PS, Calverley PM, Jones PW, et al. Randomised, doubleblind, placebo controlled study of fluticasone propionate in pa-tients with moderate to severe chronic obstructive pulmonary dis-ease: the ISOLDE trial. BMJ,2000,320:1297-1303.
  • 8Calverley PM, Anderson JA, Celli B, et al. Salmeterol and flutica-sone propionate and survival in chronic obstructive pulmonarydisease. N Engl J Med,2007,356:775-789.
  • 9McGarvey LP, John M,Anderson JA, et al. Ascertainment ofcause -specific mortality in COPD: operations of the TORCHClinical Endpoint Committee. Thorax,2007,62:411-415.
  • 10Celli B, Decramer M,Kesten S, et al. Mortality in the 4-year trialof tiotropium (UPLIFT) in patients with chronic obstructive pul-monary disease. Am J Respir Crit Care Med,2009,180:948-955.

二级参考文献29

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2Maclay JD,McAllister DA,Macnee W.Cardiovascular risk in chronic obstructive pulmonary disease.Respirology,2007,12:634-641.
  • 3Calverley PM,Anderson JA,Celli B,et al.Cardiovascular events in patients with COPD:TORCH study results.Thorax,2010,65,719-725.
  • 4Sin DD,Man SF.Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease.Circulation,2003,107:1514-1519.
  • 5Soyseth V,Brekke PH,Smith P,et al.Statin use is associated with reduced mortality in COPD.Eur Respir J,2007,29:279-283.
  • 6Mancini GB,etminan M,Zhang B,et al.Reduction of morbidity and mortality by statins,angiotensin-converting enzyme inhibitors,and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease.J Am Coll Cardiol,2006,47:2554-2560.
  • 7Mannino DM,Thorn D,Swensen A,et al.Prevalence and outcomes of diabetes,hypertension and cardiovascular disease in COPD.Eur Respir J,2008,32:962-969.
  • 8Crisafulli E,Costi S,Luppi F,et al.Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation.Thorax,2008,63:487-492.
  • 9Chakrabarti B,Nagus RM,Agarwal S,et al.Hyperglycaemia as a predictor of outcome during non invasive ventilation in decompensated COPD.Thorax,2009,64:857-862.
  • 10Poulain M,Doucet M,Major GC,et al.The effect of obesity on chronic respiratory diseases:pathophysiology and therapeutic strategies.CMAJ,2006,174:1293-1299.

共引文献8244

同被引文献92

引证文献10

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部